Evidence map›Paper›PMID 18543299›Full record

ArticleGenesis (New York, N.Y. : 2000)2008

A CK19(CreERT) knockin mouse line allows for conditional DNA recombination in epithelial cells in multiple endodermal organs.

Anna L Means, Yanwen Xu, Aizhen Zhao, Kevin C Ray, Guoqiang Gu

Open access · greenAbstract read
In one paragraph

Article in Genesis (New York, N.Y. : 2000), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 137 papers.

0numbers the graph read from it
0cells of the map it votes in
137citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

137 citing papers in PubMed, 179 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. CDK1 drives SOX9-mediated chemotherapeutic resistance in gastric cancer.Journal of experimental & clinical cancer research : CR · 2025
    Article
  6. Article
  7. Combined pharmacological targeting of CD9Cell reports. Medicine · 2025
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. VEGF-FGF Signaling Activates Quiescent CD63Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

77 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Anna L MeansProgram in Developmental Biology and the Department of Cell and Developmental Biology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Yanwen Xu
Aizhen Zhao
Kevin C Ray
Guoqiang Gu
Vanderbilt University Medical Center · US

Funding

The Mechanisms of Islet Cell Specification and DifferentiationR01DK065949 · NIDDK · VANDERBILT UNIVERSITY · PI GU, GUOQIANG · 2004 to 2017
$4.4M
NIDDK NIH HHS DK065949NIDDK NIH HHS R01 DK065949
6 · The paper itself

Abstract

Cre/LoxP-mediated DNA recombination allows for gene function and cell lineage analyses during embryonic development and tissue regeneration. Here, we describe the derivation of a K19(CreERT) mouse line in which the tamoxifen-activable CreER(T) was knocked into the endogenous cytokeratin 19 locus. In the absence of tamoxifen, leaky Cre activity could be detected only in less than 1% of stomach and intestinal epithelial cells, but not in pancreatic or hepatic epithelial tissues. Tamoxifen administration in postnatal animals induced widespread DNA recombination in epithelial cells of pancreatic ducts, hepatic ducts, stomach, and intestine in a dose-dependent manner. Significantly, we found that Cre activity could be induced in the putative gut stem/progenitor cells that sustained long-term gut epithelial expression of a Cre reporter. This mouse line should therefore provide a valuable reagent for manipulating gene activity and for cell lineage marking in multiorgans during normal tissue homeostasis and regeneration.

Indexed as

Recombination, GeneticAllelesAnimalsCell LineageDNADose-Response Relationship, DrugEpithelial CellsGenes, ReporterGene TargetingImmunohistochemistryIntegrasesIntestine, SmallKeratin-19MiceMice, Inbred C57BLMice, TransgenicCre recombinaseDNAIntegrasesKeratin-19Tamoxifen

Identifiers

PMID18543299
PMCPMC3735352
OpenAlexW2165849327

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.